(19)
(11) EP 4 816 383 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898813.1

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C07K 7/06(2006.01)
A61P 1/04(2006.01)
A61P 43/00(2006.01)
A61K 38/08(2019.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 1/04; A61K 38/08
(86) International application number:
PCT/US2024/057863
(87) International publication number:
WO 2025/117825 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.11.2023 US 202363603027 P

(71) Applicant: Soligenix, Inc.
Princeton, NJ 08540 (US)

(72) Inventors:
  • DONINI, Oreola
    Coquitlam, BC V3J 4A2 (CA)
  • SCHABER, Christopher
    Princeton, NJ 08540 (US)
  • RUMAGE, Adam
    Princeton, NJ 08540 (US)
  • STRAUBE, Richard
    Princeton, NJ 08540 (US)

(74) Representative: Winter, Brandl - Partnerschaft mbB 
Alois-Steinecker-Straße 22
85354 Freising
85354 Freising (DE)

   


(54) COMPOSITIONS AND METHODS OF TREATMENT OF CERTAIN VASCULITIS SYNDROMES